Known targets — ChEMBL curated mechanism
ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol
The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A known ✓ | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.82 |
| ▸ | TP53 | P04637 | 1/20 | 0.82 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.82 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.82 |
| ▸ | HCAR2 | Q8TDS4 | 4/20 | 0.47 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.42 |
| ▸ | GABRR2 | P28476 | 2/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | GABRR3 | A8MPY1 | 1/20 | 0.42 |
| ▸ | APEX1 | P27695 | 1/20 | 0.42 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Maleic Acid SCHEMBL988578 | 1.00 | TSHR (0.82) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL985495 | 1.00 | TSHR (0.82) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL6466117 | 0.95 | TSHR (0.90) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL342742 | 0.95 | — | — | |
| Maleic Acid SCHEMBL716254 | 0.95 | — | — | |
| Fumaric Acid SCHEMBL41492 | 0.95 | — | — | |
| Fumaric Acid SCHEMBL41491 | 0.95 | TSHR (0.90) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Maleic Acid SCHEMBL532168 | 0.95 | — | — | |
| Fumaric Acid SCHEMBL6466120 | 0.95 | TSHR (0.90) | TSHRTP53EGLN1EGLN3HCAR2 | |
| Fumaric Acid SCHEMBL2138822 | 0.95 | TSHR (0.90) | TSHRTP53EGLN1EGLN3HCAR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114766661-A | Formula and preparation method of special nutrition diet for speed and strength sports | 武汉万松堂生物医药科技有限公司 | 2022-07-22 | — | — | CN | claimed |
| EP-3083978-A1 | MEDIA FOR CELL CULTURE | Essential Pharmaceuticals, LLC (US) | 2016-10-26 | — | — | EP | claimed |
| CN-106062205-A | Cell culture medium | 基本药品有限责任公司 | 2016-10-26 | — | — | CN | claimed |
| US-20150329830-A1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2015-11-19 | — | — | US | claimed |
| WO-2015095651-A1 | MEDIA FOR CELL CULTURE | ESSENTIAL PHARMACEUTICALS, LLC (US) | 2015-06-25 | — | — | WO | claimed |
| EP-2776558-A1 | KIT COMPRISING SERUM REPLACEMENT AND LABILE FACTORS | Essential Pharmaceuticals, LLC (US) | 2014-09-17 | — | — | EP | claimed |
| CN-103958665-A | Kit comprising a serum replacement and a labile factor | ESSENTIAL PHARMACEUTICALS LLC | 2014-07-30 | — | — | CN | claimed |
| US-20130183714-A1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | MEDIMMUNE LIMITED (GB) | 2013-07-18 | — | — | US | claimed |
| US-20130130373-A1 | Kit Comprising Serum Replacement and Labile Factors | ESSENTIAL PHARMACEUTICALS, LLC (US) | 2013-05-23 | — | — | US | claimed |
| WO-2013071151-A1 | KIT COMPRISING SERUM REPLACEMENT AND LABILE FACTORS | ESSENTIAL PHARMACEUTICALS, LLC (US) | 2013-05-16 | — | — | WO | claimed |
| US-8361797-B2 | Myeloma cell culture in transferrin-free low iron medium | MEDIMMUNE LIMITED (GB) | 2013-01-29 | — | — | US | claimed |
| EP-1651754-B1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | CAMBRIDGE ANTIBODY TECH (GB) | 2007-04-11 | — | — | EP | claimed |
| US-20070031964-A1 | Myeloma cell culture in transferrin-free low iron medium | MEDIMMUNE LIMITED (GB) | 2007-02-08 | — | — | US | claimed |
| JP-2007501606-A | — | — | 2007-02-01 | — | — | JP | claimed |
| EP-1651754-A1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | Cambridge Antibody Technology Limited (GB) | 2006-05-03 | — | — | EP | claimed |
| WO-2005014800-A1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2005-02-17 | — | — | WO | claimed |
| CN-1136400-A | Fruit fragrant composite mineralizing nutrient tea | WUEN GARMENT AND DRESS PERSONA (CN) | 1996-11-27 | — | — | CN | claimed |
| CN-115943157-A | Use of plant protein homologues in culture media | 耶路撒冷希伯来大学伊森姆研究发展公司 | 2023-04-07 | — | — | CN | disclosed |
| WO-2005014800-A1 | MYELOMA CELL CULTURE IN TRANSFERRIN-FREE LOW IRON MEDIUM | CAMBRIDGE ANTIBODY TECHNOLOGY LIMITED (GB) | 2005-02-17 | — | — | WO | disclosed |
| CN-1136400-A | Fruit fragrant composite mineralizing nutrient tea | WUEN GARMENT AND DRESS PERSONA (CN) | 1996-11-27 | — | — | CN | disclosed |